Irony alert: If you’re going to publish in the Journal of Human Behavior in the Social Environment, you’d better be able to play well with others.
Not so, it seems, with a certain Darrel Montero. Montero, an associate professor in the School of Social Work at Arizona State University, and his colleagues have lost their 2012 paper in the journal for what appears to be a case of data theft.
As the retraction notice explains:
Continue reading Social work researchers lose paper for misuse of data
The Journal of Pediatric Nursing has retracted a 2013 article (meeting abstract, really) on growth hormone after the drug company that employed the authors cried “take it back.”
The research appears to have been presented at a meeting of the Pediatric Endocrinology Nursing Society, and looked at inefficiency in the use of devices for administering growth hormone. All but one of the authors is listed as working for Novo Nordisk, an international pharmaceutical firm.
Here’s the notice: Continue reading Nursing journal pulls Novo Nordisk growth hormone paper over data provenance
Sometimes, authors and journals editors seem to think a bit of mystery is a good thing. Take a recent retraction in Brain.
Here’s the notice for “Selective impairment of hand mental rotation in patients with focal hand dystonia:” Continue reading “Ambiguities in the presentation of some of the data” lead to an ambiguous retraction notice
Physica B: Condensed Matter has retracted a 2013 paper by a group from Morocco and France for, well, inappropriate condensation of printed matter.
The article, “Granular and intergranular conduction in La1.32Sr1.68Mn2O7 layered manganite system,” came mostly from a team of physicists at University Ibn Zohr, and appeared in June.
According to the retraction notice: Continue reading Plagiarism leads to retraction of conduction paper
Ariel Fernandez, an Argentine chemist (who claims to hold the fastest-awarded PhD from Yale) and the subject of institutional investigations at multiple universities, has corrected several papers recently. What makes the moves particularly unusual — and interesting — is the stated reason for the amendments: disclaiming any funding from the National Institutes of Health for the work.
Fernandez was the recipient in 2005 of a $275,880 award “Protein packing defects as functional markers and drug targets.” The following year he received $294,217, and in 2007, $284,461, for the same four-year project, if we’re reading the link correctly.
Fernandez, readers of this blog might recall, threatened us with legal action when we wrote last spring about an expression of concern regarding his 2011 paper in BMC Genomics, “Subfunctionalization reduces the fitness cost of gene duplication in humans by buffering dosage imbalances.” According to that notice: Continue reading Researcher who threatened Retraction Watch with lawsuit corrects funding source for several papers
The temporary withdrawal of a Molecular Plant paper had us scratching our heads, but the issue seems to be explained by a glitch.
If you click on this version of “Application of the CRISPR–Cas System for Efficient Genome Engineering in Plants” (subscription required), you see this:
This paper has been withdrawn pending a decision by the Editorial Board
But that page also says that the latest version of the paper was published on October 3. Clicking on that version sends you to the paper, which begins: Continue reading Plant journal withdraws paper — or does it?
On Wednesday, we brought you the story of a retraction by Gerold Feuer, a State University of New York (SUNY) Upstate Medical Center stem cell scientist whom the university had found to have misused grants. He was suspended, but successfully fought that action. We had asked Feuer for comment at that time, and he has now responded:
SUNY Upstate Medical University’s decision to widely publicize the recent decision by the journal Stem Cells to retract an article from my laboratory is a vindictive and retaliatory campaign to defame my scientific credentials in the press and to my scientific colleagues.
I unequivocally state that the data in all published manuscripts is valid and sound and is not falsified or fabricated. SUNY UMU unilaterally requested a retraction from Stem Cells, despite the fact that the federal Office of Research Integrity (ORI) has not yet ruled on these allegations. It is not surprising that UMU has decided to publicize this retraction in a public forum as a second attempt to force me from my tenured faculty position and circumvent decision of the employment arbitrator and the New York Supreme Court.
To date SUNY UMU has refused to abide by the arbitrator’s “binding” decision to reinstate my faculty position and has failed to pay proper back-wages. The arbitrator evaluated operations of my spin-off company, Humurine Technologies, and stated: Continue reading Stem cell scientist says data in retracted paper “is not falsified or fabricated”
A group of authors from Saudi Arabia and Egypt has lost their 2012 paper in the International Journal of Dentistry for what appears to be a case of large-scale lifting of text from a previously published paper.
The now-retracted article was titled “A Prospective Study of Early Loaded Single Implant-Retained Mandibular Overdentures: Preliminary One-Year Results,” and has yet to be cited, according to Thomson Scientific’s Web of Knowledge.
From the abstract: Continue reading Say “Argh!” Dental journal extracts paper for plagiarism
About a month ago, we reported on a retraction by Pamela Ronald, of the University of California, Davis, and colleagues. We noted then that this was a case of scientists doing the right thing. Ronald contacted us after that post ran, and let us know that there would be another retraction shortly. That retraction notice has now appeared, in Science: Continue reading Pamela Ronald does the right thing again, retracting a Science paper
Stem Cells and Development has retracted a paper it published earlier this year after the leader of the study reported that the data were unreliable.
The paper, “Derivation and Genetic Modification of Embryonic Stem Cells from Disease-Model Inbred Rat Strains,” came from the lab of Aron Geurts, of the Medical College of Wisconsin.
According to the retraction notice: Continue reading Embryonic stem cell paper retracted for fabrication